Australia markets open in 4 hours 36 minutes

Castle Biosciences, Inc. (CSTL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
24.10-0.31 (-1.27%)
As of 03:24PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-30,796
-57,466
-67,138
-31,292
-10,284
Depreciation & amortisation
12,778
12,330
10,543
3,407
472
Deferred income taxes
-236
-223
-1,877
-8,736
0
Stock-based compensation
50,369
51,219
36,321
21,740
8,309
Change in working capital
-13,779
-6,630
-7
-4,102
9,148
Accounts receivable
-14,809
-14,930
-6,218
-4,631
1,663
Inventory
-3,125
-3,962
-1,680
327
-980
Accounts payable
1,389
5,707
582
-182
169
Other working capital
-6,457
-19,247
-47,287
-22,466
5,114
Other non-cash items
603
635
-18,129
-
823
Net cash provided by operating activities
12,978
-5,626
-41,655
-18,983
9,865
Cash flows from investing activities
Investments in property, plant and equipment
-19,435
-13,621
-5,632
-3,483
-4,751
Acquisitions, net
-
0
-26,966
0
-
Purchases of investments
-219,746
-189,075
-134,689
0
-
Sales/maturities of investments
186,700
186,500
0
-
-
Other investing activities
-
-
547
-63,184
-
Net cash used for investing activities
-52,468
-16,183
-166,545
-66,657
-4,748
Cash flows from financing activities
Debt repayment
-143
-142
-122
-8
-27,359
Common stock issued
-
-
-
0
330,041
Other financing activities
-5,294
-5,134
-1,688
-1,117
-
Net cash used provided by (used for) financing activities
7,618
-2,298
1,515
5,421
305,890
Net change in cash
-31,872
-24,107
-206,685
-80,219
311,007
Cash at beginning of period
114,821
122,948
329,633
409,852
98,845
Cash at end of period
82,949
98,841
122,948
329,633
409,852
Free cash flow
Operating cash flow
12,978
-5,626
-41,655
-18,983
9,865
Capital expenditure
-19,435
-13,621
-5,632
-3,483
-4,751
Free cash flow
-6,457
-19,247
-47,287
-22,466
5,114